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The incorporation of biomarkers in the actually used risk scores seem to be
helpful for early identifying atrial fibrillation (AF) patients at higher risk. The aim
of this critical review of the scientific literature is to investigate the potential
clinical significance of red blood cell distribution width (RDW) in AF. A
systematic electronic search was carried out to identify all articles describing an
epidemiological association between RDW and AF in adult human populations.
Data abstraction was conducted on a final number of 35 articles (13 cross-
sectional, 12 prospective and 10 retrospective studies). The results of these
epidemiological investigations were all virtually concordant to emphasize that an
enhanced RDW value is not only a predictive factor and a marker of AF but its
measurement may also be helpful for predicting the risk of developing many
adverse complications in patients with AF, such as recurrence and duration of
AF, hospitalization for heart failure, bleeding, left atrial thrombosis and stasis,
thromboembolic events and mortality. AF patients with RDW values exceeding
the local reference range may be more aggressively investigated and managed, in
order to identify and attenuate the impact of possible underlying disorders
causing both anisocytosis and AF.
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Core tip: This critical review of the scientific literature aims to investigate the potential
clinical significance of red blood cell distribution width (RDW) in atrial fibrillation
(AF). We concluded that an enhanced RDW value is not only a predictive factor and a
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marker of AF but its measurement may also be helpful for predicting the risk of
developing many adverse complications in patients with AF, such as recurrence and
duration of AF, hospitalization for heart failure, bleeding, left atrial thrombosis and
stasis, thromboembolic events and mortality.
Citation: Lippi G, Cervellin G, Sanchis-Gomar F. Red blood cell distribution width: A marker





Atrial  fibrillation  (AF)  is  the  most  common  heart  arrhythmia  worldwide [1].
Worryingly, AF is related to higher rates of stroke and mortality[2]. Many risk scores
and biological  markers have been identified and developed to predict  future AF
events. Among the most frequently used and validated risk scores based on clinical
parameters  are  CHADS2 [congestive heart  failure,  hypertension,  age ≥ 75 years,
diabetes,  and stroke or transient ischemic attack (2 points)] and CHA2DS2-VASc
[cardiac failure or dysfunction, hypertension, age 65-74 (1 point) or ≥ 75 years (2
points), diabetes mellitus, and stroke, TIA or thromboembolism (2 points) –vascular
disease,  and sex category (female)][3,4].  In addition,  biomarkers may significantly
contribute to obtain additional information regarding the risk that could influence the
management of AF. Therefore, there is also an increasing interest in determining
whether biomarkers themselves or in combination with clinical risk scores enhances
prognostic accuracy for thromboembolism and mortality in AF patients[5,6]. A wide
range of biomarkers have been evaluated as predictors and/or prognostics, such as
cardiac troponin I  and T,  natriuretic  peptides,  D-dimer,  CRP,  galectin-3,  growth
differentiation factor-15, among others[1,5,7,8].
The incorporation of biomarkers in the actually used risk scores seem to be helpful
for early identifying AF patients at higher risk (i.e., enhanced risk for stroke, systemic
embolic event or death), determining also their eligibility for anticoagulation and/or
individualizing the most appropriate treatment strategy. Biomarkers are dynamic,
and  for  that  reason,  they  are  also  highly  recommended  to  be  included  into
management of patients with AF. Therefore, knowledge of new biomarkers related to
AF may provide clinicians with more potential tools to quickly identify patients at
higher risk of AF, attenuate its occurrence, improve its management, and decrease the
risk of adverse events in patients with AF.
The  search  for  hematological  predictors  of  AF  commenced  in  1987  with  the
publication of a seminal study by Imataka et al[9],  who demonstrated that plasma
volume and erythrocyte biology may be significantly perturbed in patients with AF.
Ten years later, Takahashi et al[10] first showed that erythrocyte size was altered both
before and after the onset of chronic AF, thus leading to way to subsequent research
aimed to define whether high heterogeneity of erythrocytes volumes, conventionally
known as anisocytosis, may have clinical significance in AF.
Anisocytosis,  defined as  the  presence  of  red  blood cells  (RBCs)  with  a  broad
heterogeneity of size and volume in peripheral blood, can be reliably estimated by the
vast majority of modern hematological analyzers using different techniques, which
provide a similar final  index called RBC distribution width (RDW)[11].  The RDW,
which is not directly measured by the analyzers, but can be calculated as standard
deviation (SD) of the mean corpuscular volume (MCV), and is usually expressed in
absolute value (i.e., RDW-SD) or as the coefficient of variation [i.e., RDW-CV: (RDW-
SD)/(MCV) × 100]. Albeit largely instrument-dependent, the reference range of RDW-
CV  is  usually  comprised  between  11.5%-14.5%[12].  Increased  RDW  values,  thus
reflecting  anisocytosis,  may  be  due  to  many  pathological  conditions  including
congenital erythrocyte disorders (i.e., β-thalassemia, sickle cell disease, hereditary
spherocytosis),  anemia (e.g.,  due to iron,  folate  or  vitamin B deficiencies),  blood
transfusions, some forms of hemolytic anemias, oxidative stress, inflammation and
impaired renal function[13-15]. Since the measurement of RDW has now become a useful
part in diagnostic and prognostic assessment of many cardiovascular disorders such
as acute coronary syndrome (ACS), heart failure and venous thromboembolism[16,17],
the aim of this critical review of the scientific literature is to investigate the potential
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clinical significance of measuring RDW in patients with, or at risk of, AF.
SEARCH STRATEGY
A systematic electronic search was carried out using the three well-recognized and
widely accessed scientific databases (i.e., Medline interface PubMed, Web of Science
and Scopus/EMBASE)[18], with no date or language limits, to identify all articles which
described the association between RDW and AF in epidemiological investigations
involving human adult populations (cross-sectional, retrospective and prospective
studies). The following keywords were used: “atrial fibrillation” AND “red blood cell
distribution width” OR “RDW”. The bibliographic references of selected items were
also carefully checked for identifying additionally relevant documents.  The title,
abstract and full text of the articles were accurately reviewed by two authors (Lippi G
and Cervellin G), and potential disagreement for inclusion was eventually resolved by
the opinion of the third author. Although no meta-analysis was specified before the
electronic search, since it was already clear that the studies could not be combined
due to large heterogeneity in sample size, setting, and endpoints, it was our aim to
explore whether this approach would still be possible after analyzing the data of the
included studies.
SEARCH RESULTS
The search strategy retrieved a total number of 70 documents after elimination of
replicates among the three scientific search platforms. Thirty five studies ought to be
excluded since they did not match our search criteria (Figure 1). Data abstraction was
hence conducted on a  final  number  of  35  articles  describing an epidemiological
association between RDW and atrial  fibrillation in adult  populations,  published
between  the  years  2010  and  2019  (13  cross-sectional,  12  prospective  and  10
retrospective studies) (Figure 1). It was finally decided that, as predictable, a meta-
analysis was unfeasible due to large heterogeneity of the different studies (difference
in nature, clinical settings, and endpoints, sample size from 49 to over 69000, no clear
description of comorbidities in all studies, use of rather different RDW thresholds)
(Table 1).
DESCRIPTION OF STUDIES OUTCOME
The first  epidemiological  investigation which could be  identified in  this  critical
literature  review  was  published  in  2010  by  Horne  and  collaborators[19].  In  this
prospective investigation, based on the Intermountain Heart Collaborative Study, a
total number of 3927 patients undergoing coronary angiography were evaluated after
1 year and 30 d, with the aim of defining the frequency of incident cardiovascular
disorders and complications (including AF). When patients were classified according
to quintiles of RDW, the frequency of incident AF steadily increased from the lowest
up to the highest (i.e.,  from 2% to 14%) RDW quintiles. A highly significant trend
towards increasing frequency of AF was consistently observed across RDW quintiles
(P < 0.001).
Providência  et  al[20]  carried  out  a  cross-sectional  study including  247  patients
presenting with  symptomatic  AF to  the  emergency department,  who were  then
subjected to transesophageal echocardiography for ruling out left atrial appendage
thrombus. Overall, eft atrial appendage thrombus was evidenced in 21/247 (8.5%) of
all  AF patients,  and its  presence was found to be significantly  more frequent  in
patients with RDW ≥ 15.0% than in those with lower RDW values (14.8% vs 5.4%; P =
0.013).
Liu et al[21] carried out another cross-sectional study including 133 patients with
paroxysmal AF and 101 healthy controls. In multivariate logistic regression analysis, a
RDW value > 12.55% was associated with a 63% enhanced risk of AF (odds ratio, 1.63;
95%CI: 1.01-2.61).
Ertaş  et  al[22]  retrospectively  studied  132  patients  undergoing  nonemergency
coronary artery bypass graft (CABG) surgery. A RDW > 13.45% was associated with a
nearly 1.5-fold increased risk of new-onset AF (hazard ratio 1.48; 95%CI: 1.07-2.06).
The same team of authors published another cross-control study, in which RDW was
measured in 126 patients with non-valvular AF (39 with stroke and 87 without) and in
126 healthy controls with no AF[23]. The value of RDW was found to be significantly
higher in AF patients with (14.1% ± 1.7%) or without stroke (14.3% ± 1.8%) compared
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Table 1  Summary and concise description of the studies
Authors Study design Study population Endpoints Outcome
Horne et al[19], 2010 Prospective 3927 patients undergoing
coronary angiography,






with the frequency of
incident AF
Providência et al[20], 2013 Cross-sectional 247 patients presenting with
symptomatic AF
Association with outcomes of
transesophageal
echocardiography
High RDW associated with
left atrial appendage
thrombosis
Liu et al[21], 2014 Cross-sectional 133 patients with paroxysmal
AF and 101 healthy controls
Difference between groups High RDW independently
associated with AF
Ertaş et al[22], 2013 Retrospective 132 patients undergoing
nonemergency CABG
Risk of new-onset AF until
hospital discharge
RDW independently
predicted the risk of
developing AF
Ertaş et al[23], 2013 Cross-sectional 126 patients with AF (39 with
stroke and 87 without) and
126 healthy controls
Difference among groups RDW significantly higher in
patients with AF than in
controls, but non different
between AF patients with or
without stroke





Güngör et al[25], 2014 Cross-sectional 117 patients with AF and 60
health control subjects
Difference among groups RDW significantly higher in
AF patients than in controls
Adamsson Eryd et al[26],
2014
Prospective 27124 subjects free from AF at
enrollment, followed-up for
13.6 yr
Risk of developing AF RDW independently
predicted the risk of
developing AF
Sarikaya et al[27], 2014 Cross-sectional 126 hypertensive patients (63
with AF and 63 without)
Difference among groups High RDW significantly
associated with AF
Gurses et al[28], 2015 Prospective 299 AF patients undergoing
cryoballoon-based ablation,




predicted the risk of








Risk of AF lasting > 5 min
during hospitalization
RDW independently
predicted the risk of
postoperative AF
Wan et al[30], 2015 Prospective 300 patients with AF
followed-up for a median up
period of 3.2 yr
Risk of adverse clinical
outcomes
RDW independently
predicted the risk of major
adverse events and death
Lee et al[31], 2015 Prospective 567 patients with newly
diagnosed paroxysmal AF
Risk of adverse clinical
outcomes
RDW independently
predicted the risk of new-
onset stroke, composite
outcome and bleeding
Zhao et al[32], 2015 Cross-sectional 90 AF patients, 24 with
evidence of left atrial
thrombus (n = 11) or left
atrial spontaneous echo
contrast (n = 13)
Evidence of left atrial
thrombus or left atrial
spontaneous echo contrast
RDW associated with
presence of left atrial
thrombus or left atrial
spontaneous echo contrast
Aksu et al[33], 2015 Prospective 49 patients with AF followed-
up for 10 mo




Cross-sectional 101 patients with sick sinus
syndrome (32 with AF)
Difference between groups High RDW independently
associated with AF




Risk of new-onset AF
throughout hospitalization
RDW independently
predicted the risk of new-
onset AF
Yanagisawa et al[36], 2016 Prospective 757 AF patients undergoing
radiofrequency catheter
ablation followed-up for 22
mo
Risk of adverse clinical
outcomes
RDW independently
predicted the risk of recurrent
AF and major adverse events
Vizzardi et al[37], 2016 Retrospective 232 patients with stable heart
failure 1 yr after enrolment
Risk of adverse events 1 yr
after enrolment
RDW independently
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Risk of postoperative AF RDW independently
predicted the risk
postoperative AF
Zhang et al[39], 2017 Prospective 172 patients with nonvalvular
AF undergoing catheter
ablation, followed-up for 3
mo
Risk of bleeding RDW predicted the risk of
bleeding events
Al-Kindi et al[40], 2017 Retrospective 46720 patients with a







predicted the risk of AF
Liu et al[41], 2017 Cross-sectional 99 patients with AF,
categorized according to their
CHADS2 and CHA2DS2-
VASc scores






Saliba et al[42], 2017 Retrospective 69412 patients with AF Risk of death 2 yr after study
entry
RDW independently
predicted the risk of death;
persistently increased RDW
values at two time points
stronger predictors of death
than a single increased RDW
value
Kaya et al[43], 2017 Cross-sectional 619 patients with AF (325
with left atrial stasis and 294
without)
Association with left atrial
stasis
High RDW independently
associated with left atrial
stasis
Cha et al[44], 2017 Retrospective 5082 patients with AF Risk of thromboembolic
events during 5.2 yr
High peak RDW value
during follow-up
independently associated
with the risk of
thromboembolic events
Nam et al[45], 2017 Cross-sectional 103 healthy control subjects
and 117 patients with AF
patients, 65 of whom with
paroxysmal and 52 with
persistent AF
Difference among groups RDW values non significantly
different between controls
and all AF cases; RDW values
significantly higher in
patients with persistent than
in those with paroxysmal AF
Wasilewski et al[46], 2017 Retrospective 1734 patients with LVEF ≤
35% and without ACS
Risk of AF after 660 d High RDW independently
predicted the risk of AF
Kilicgedik et al[48], 2018 Retrospective 358 patients after who
underwent CABG surgery (57
with PSAF and 301 patients
with non-PSAF)
Risk of AF after CABG
surgery
High RDW was predictive of
PSAF
Cerşit et al[47], 2018 Retrospective 50 patients with AF and 62
age- and sex- matched
controls, who had presented
with ACS
Association and predictive
value of RDW with AF in
patients with ACS.
High RDW was associated
with AF and had long-term
predictive value
Ozsin et al[49], 2018 Retrospective 93 patients who underwent
off-pump CABG (24 patients
with PSAF and 69 without
PSAF)
Association and predictive
value of RDW for
development PSAF
Elevated RDW levels may be
predictive of PSAF
Pilling et al[50], 2018 Prospective 240477 healthy UK Biobank
study volunteers aged 40 ± 70
yr at baseline (follow-up ≤ 9
yr)
Association of RDW with AF
in healthy subjects.
High RDW was associated
with AF and had long-term
predictive value
Han et al[51], 2019 Cross-sectional 303 patients with nonvalvular
AF living at low altitude (3.5
m above the sea level) and
high altitude (2260 m above
the sea level).
Association of RDW with AF
in subjects living at low and
high altitude.
Elevated RDW levels were an
independent risk marker for
AF and is affected by type of
AF and altitude
Jurin et al[52], 2019 Prospective 579 patients with AF (non-
permanent and permanent
AF ), with a median follow-
up time of 21 mo






Li et al[53], 2019 Cross-sectional 106998 Chinese individuals Relationship between RDW
and AF
Elevated RDW is significantly
related to higher prevalence
of AF in a general Chinese
population
AF: Atrial fibrillation; RDW: Red blood cell distribution width; LVEF: Left ventricular ejection fraction; CABG: Coronary artery bypass graft; ACS: Acute
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coronary syndrome; PSAF: Post-surgery atrial fibrillation.
to  the  control  population (13.2% ± 0.9%),  but  its  value did not  differ  among AF
patients with or without stroke (P > 0.05).
Kurt et al[24] measured RDW in 320 patients with AF and found that those with a
higher CHA2DS2-VASc score had also significantly higher RDW values than those
with a lower CHA2DS2-VASc score (14.9% ± 2.7% vs  13.6% ± 1.7%; P  < 0.001).  A
highly significant correlation could be observed between RDW and CHA2DS2-VASc
score (r  = 0.383;  P  < 0.001).  In multivariate analysis,  a  RDW value > 14.05% was
associated with a 25% higher risk (odds ratio, 1.25; 95%CI: 1.11-1.42) of having high
CHA2DS2-VASc score (i.e., ≥ 2).
In an ensuing investigation, Güngör et al[25] studied 117 patients with AF and 60
healthy control subjects, concluding that RDW values were significantly higher in AF
cases than in controls (13.4% vs 12.6%; P = 0.01). In multivariate regression analysis, a
RDW > 12.9% was associated with a nearly 4-fold higher risk (odds ratio, 4.18; 95%CI:
2.15-8.15) of AF.
Adamsson Eryd et  al[26]  carried out  a  large  prospective  study including 27124
subjects free from AF at enrollment, who were followed-up for a mean period of 13.6
years. Subjects in the highest quartile of RDW had a 33% enhanced risk (hazard ratio,
1.33; 95%CI: 1.16-1.53) of developing AF on follow-up compared to those in the lowest
quartile. Moreover, each 1 SD increase of RDW value was associated with a 8% higher
risk (hazard ratio, 1.08; 95%CI: 1.04-1.12) of incident AF.
Sarikaya et al[27] studied 126 patients with hypertension (63 with AF and 63 without)
and reported that RDW values were significantly higher in patients with AF than in
those without (15.1% ± 1.6% vs  14.0% ± 1.1%; P  = 0.001).  In multivariate logistic
regression analysis, a RDW value > 14.2% was found to be independently associated
with 1.8-fold higher risk (odds ratio, 1.85; 95%CI: 1.22-2.79) of AF.
Gurses et al[28] measured RDW in 299 patients with paroxysmal or persistent AF
undergoing cryoballoon-based ablation, and who were then followed-up for a mean
period of 24 mo. A RDW value > 13.75% was independently associated with both
early (hazard ratio, 6.39; 95%CI: 3.41-11.97) and late (hazard ratio, 1.88; 95%CI: 1.41-
2.50) recurrence of AF, enhanced left atrial diameter (hazard ratio, 3.09; 95%CI: 1.81-
5.27), as well as with duration of AF (hazard ratio, 1.04; 95%CI: 1.01-1.07).
Korantzopoulos et al[29] studied 109 patients undergoing elective cardiac surgery,
who were then prospectively followed-up throughout hospitalization. In multivariate
logistic regression analysis, a RDW > 13.35% was independently associated with a
46% higher risk (odds ratio, 1.46; 95%CI: 1.08-1.99) of developing postoperative AF
during hospital stay.
Wan et al[30] carried out a prospective study including 300 patients with AF who
were followed-up at a median period of 3.2 years. Patients in the fourth quartile of
RDW values had a 2.7-fold higher risk (hazard ratio, 2.70; 95%CI: 1.35-5.83) of major
adverse events (all-cause mortality, ACS, stroke and major hemorrhage) and a 3.8-fold
higher risk (hazard ratio, 3.83; 95%CI: 1.53-9.58) of death during follow-up.
Lee  et  al[31]  measured  RDW  values  in  567  patients  with  newly  diagnosed
paroxysmal  AF,  who  were  followed-up  for  a  median  period  of  4.8  years.  In
multivariate analysis, an increased RDW value (no indications provided on the cut-off
used) was independently associated with 47% higher risk (hazard ratio, 1.47; 95%CI:
1.05-2.05) of new-onset stroke, 26% higher risk (hazard ratio, 1.26; 95%CI: 1.02-1.54) of
composite outcome (mortality, new-onset stroke and hospitalization for heart failure),
and 74% enhanced risk of bleeding (hazard ratio, 1.74; 95%CI: 1.28-2.36) throughout
follow-up.
Zhao  et  al[32]  retrospectively  analyzed  a  local  echocardiology  database  for
identifying all AF patients who underwent transesophageal echocardiography before
catheter ablation or electrical cardioversion. The final study population consisted of 90
AF patients, 24 of whom had evidence of left atrial thrombus (n = 11) or left atrial
spontaneous  echo  contrast  (n  =  13).  The  mean  RDW  value  was  found  to  be
significantly higher in patients with these two complications than in those without
(13.0% ± 0.9% vs 12.6% ± 0.8%; P = 0.039).
Aksu et al[33] studied 49 patients with symptomatic paroxysmal AF who underwent
cryoballoon ablation and were then followed-up for a mean period of 10 mo. Patients
with AF recurrence on follow-up had significantly higher RDW values than those
without (16.1% ± 1.4% vs 14.9% ± 0.5%; P = 0.033). Interestingly, the post-ablation
RDW value remained almost unchanged in patents without recurrence of AF, but in
those with AF recurrence the RDW significantly increased from 16.1% ± 1.4% to 16.3%
± 2.4% (P < 0.05).
In another study, Korantzopoulos et al[34] measured RDW in 101 patients with sick
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Figure 1
Figure 1  Search strategy and search results.
sinus  syndrome  (32  with  AF),  and  found  that  a  RDW  value  >  14.0%  was
independently associated with AF (odds ratio, 1.58; 95%CI: 1.06-2.85).
Karataş  et  al[35]  studied  621  patients  with  ST-elevation  myocardial  infarction
undergoing primary percutaneous coronary intervention, and who were followed-up
throughout hospitalization. Patients with RDW > 13.4% had a 55% higher risk (odds
ratio, 1.55; 95%CI: 1.20-2.01) of developing new-onset AF until hospital discharge.
Yanagisawa et al[36]  measured RDW in 757 patients undergoing radiofrequency
catheter ablation for AF, who were then followed-up for a mean period of 22 mo. In
multivariate linear regression analysis, a RDW value > 13.9% was associated with 20%
higher risk (hazard ratio, 1.20; 95%CI: 1.01-1.40) of recurrent AF in patients with heart
failure, whilst no significant association was found in those without heart failure. In
patients with heart failure, a RDW value > 14.8% was also associated with 83% higher
risk (hazard ratio, 1.83; 95%CI: 1.13-2.72) of developing major adverse events (all-
cause mortality, hospitalization for heart failure and cerebral ischemia) during follow-
up.
Vizzardi et al[37] carried out a retrospective study including 232 patients with stable
heart  failure,  whose  clinical  outcome  was  assessed  1  year  after  enrolment.  In
multivariate logistic regression analysis, a RDW value > 14.45% was independently
associated  with  3.9-fold  enhanced  risk  (odds  ratio,  3.89;  95%CI:  1.04-14.55)  of
cardiovascular death and/or hospitalization for heart failure in the first year after
enrolment.
Geçmen et al[38] carried out a prospective study including 94 patients undergoing
isolated on-pump CABG surgery, who were followed-up until discharge from the
cardiovascular intensive care unit. In univariate analysis, higher RDW values were
associated with a 41% higher risk (odds ratio, 1.41; 95%CI: 1.01-1.96) of postoperative
AF during cardiovascular intensive care unit stay. The cut-off value of RDW was
unavailable in the publication and the association between RDW and postoperative
AF was not tested in multivariate analysis.
Zhang et al[39] measured RDW in 172 patients diagnosed with nonvalvular AF, who
were followed up for 3 mo after catheter ablation. The overall number of bleeding
events was found to be higher in patients with RDW values > 12.8% than in those
with lower RDW values (11.8% vs 3.4%). Interestingly, the diagnostic efficiency (i.e.,
area under the receiver operating characteristics curve; AUC) for predicting bleeding
occurrence was higher for RDW than for activated partial thromboplastin time (0.737
vs 0.558; P < 0.01).
Al-Kindi  et  al[40]  used a  large commercial  database including electronic  health
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records of many participating hospitals, with the aim of identifying patients aged 18
years or older with a diagnosis of HIV and who had at least  one available RDW
measurement. The search allowed the extraction of a total number of 46720 records
(mean or median follow-up period for development of cardiovascular complications
is  unavailable  in  the  article).  In  these  HIV  patients,  a  RDW  value  >  14.5%  was
independently associated with a 96% higher risk (odds ratio, 1.96; 95%CI: 1.64-2.33) of
incident AF.
Liu et al[41] studied 99 patients with AF, divided into two groups according to their
CHADS2 and CHA2DS2-VASc scores. In multivariate logistic regression analysis, a
RDW value > 12.55% was found to  be  significantly  associated with higher  (≥  2)
CHADS2 score (odds ratio, 2.18; 95CI%: 1.14-3.22), whilst a RDW value > 12.75% was
found to be significantly associated with higher (≥ 2) CHA2DS2-VASc score (odds
ratio, 5.75; 95%CI: 3.70-7.79).
Saliba  et  al[42]  searched  the  electronic  database  for  a  large  national  health
maintenance for identifying all patients diagnosed with AF in whom at least two
RDW measurements were performed 1 year before study entry. Mortality data were
retrospectively reviewed for up to 2 years after patients inclusion in the database. The
electronic  search identified a  total  of  69412  records.  A RDW value  >  14.5% was
independently associated with a 49% increased risk (hazard ratio, 1.49; 95%CI, 1.43-
1.55)  of  all-cause  mortality  during  the  follow-up  period.  More  importantly,
persistently  increased  RDW  values  at  the  two-time  points  were  independently
associated with an even higher risk of death during the same follow-up period (HR,
1.70; 95%CI: 1.61-1.79).
Kaya et al[43]  analyzed the data of 619 AF patients undergoing transesophageal
echocardiography examination before cardioversion or AF ablation. In multivariate
regression analysis, a RDW value > 13.7% was associated with a 67% increased risk of
left atrial stasis (odds ratio, 1.67; 95%CI: 1.44-1.94).
Cha et al[44]  carried out a retrospective study including 5082 patients with non-
valvular AF, who were followed-up for a mean period of 5.2 years. The RDW was
measured several times during follow-up, allowing to identify nadir (i.e., the lowest),
peak (i.e., the highest) and mean RDW values. Among the various RDW measures, a
peak value ≥ 13.9% was independently associated with a 66% enhanced risk (odds
ratio, 1.66; 95%CI: 1.41-1.96) of thromboembolic events, including ischemic stroke and
systemic embolism.
Nam et  al[45]  carried  out  a  cross-sectional  study including 103  healthy  control
subjects and 117 patients with AF, 65 of whom with paroxysmal AF and 52 with
persistent AF. Overall,  no significant difference was found in mean RDW values
between controls and AF cases (13.4% ± 1.6% vs  13.5% ± 0.8%; P  = 0.343),  whilst
patients with persistent AF exhibited significantly higher mean RDW values than
those with paroxysmal AF (13.9% ± 0.9% vs 13.3% ± 0.6%; P < 0.05).
Wasilewski et al[46] performed a sub-analysis of the COMMIT-HF (COnteMporary
Modalities In Treatment of Heart Failure) registry, including 1734 patients with left
ventricular  ejection  fraction  ≤  35%  and  without  ACS  at  baseline,  who  were
retrospectively investigated for a median period of 660 d. Patients in the highest RDW
tertile had a more than double risk of developing AF on follow-up compared to those
in the lowest tertile (44.1% vs 20.2%; P < 0.01).
Cerşit et al[47] investigated the association between RDW and AF in 50 patients with
and without AF after an ACS. RDW was significantly higher in patients with AF than
the control group (14.5% ± 2% vs  12.6% ± 1%, P  < 0.001). A RDW of > 11.7% also
predicted AF (sensitivity 56% and specificity of 64%; AUC = 0.637, P < 0.001).
Kılıcgedik et al[48] evaluated the RDW values in 358 patients who underwent CABG
surgery  [57  with  post-surgery  AF  (PSAF)  and  301  patients  with  non-PSAF].
Interestingly, RDW values were significantly higher in PSAF group. In multivariate
analysis, RDW [OR:1.16 (95%CI: 1.0-1.36), P = 0.05] was found to be predictive for
PSAF (68.4% sensitivity and 51.2% specificity;  P  = 0.001).  Likewise,  Ozsin et  al[49]
analyzed the RDW levels in 93 patients who underwent off-pump CABG surgery. 24
patients developed PSAF while 69 did not. RDW was significantly correlated with
PSAF and was also found to be predictive for PSAF (79.2% sensitivity and 65.2%
specificity; P = 0.001).
Pilling et al[50] analyzed the RDW levels in 240477 healthy volunteers (40 ± 70 at
baseline) during a follow-up period of ≤ 9 years. Higher RDW levels (≥ 15% variation,
n = 6050) was associated with AF (sHR 1.37: 1.21 to 1.55). RDW was also predictive of
new-onset AF.
Han et al[51] investigated the effects of low altitude (3.5 m above the sea level) and
high  altitude  (2260  m  above  the  sea  level)  on  RDW  levels  of  303  patients  with
nonvalvular AF. RDW levels were higher in AF than control individuals (P < 0.05)
and higher in persistent AF than paroxysmal AF (P  < 0.05) in both low and high
altitudes. Moreover, RDW, was independently associated with AF in low altitude
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(RDW, OR:  1.687,  95%CI:  1.021–2.789;  P  <  0.05),  whereas  it  was an independent
predictor for AF (RDW, OR: 1.755, 95%CI: 1.179–2.613; P < 0.05) in high altitude.
Jurin et al[52] recruited 579 patients with AF, 412 with non-permanent AF and 167
with permanent AF, and followed-up the patients with non-permanent AF during a
median time of 21 mo. The main endpoint was progression of non-permanent AF to
permanent  AF.  109  patients  (26.6%)  progressed  to  permanent  AF.  Moreover,
increased  RDW  levels  showed  a  significant  independent  association  with  the
progression to permanent AF (HR 1.19, 95%CI: 1.03–1.39, P = 0.022).
Finally, Li et al[53] recently examined the relationship between RDW and AF in a
general Chinese population (106998 subjects). The authors concluded that RDW was
significantly related to a higher prevalence of AF; the OR (95%CI) of AF for increasing
tertiles of RDW were 1.00 (reference), 1.08 (0.69, 1.67), and 2.65 (1.75, 4.07) (P for trend
< 0.0001), respectively.
Taken together, the results of these epidemiological studies, as well as results from
two systematic reviews and meta-analysis recently published[54,55], are all virtually
concordant to emphasize that an enhanced RDW value not only is a predictive factor
and a marker of AF but its measurement may also be helpful for predicting the risk of
developing many adverse complications in patients with AF, such as recurrence and
duration of AF, hospitalization for heart failure, bleeding, left atrial thrombosis and
stasis, thromboembolic events (including new-onset stroke) and mortality.
ANISOCYTOSIS IN ATRIAL FIBRILLATION: ACTIVE PLAYER
OR BYSTANDER?
There are at least two biological explanations which can be brought for justifying the
strong epidemiological association observed between anisocytosis and AF, either of
which is plausible (Figure 2).
The first and rather predictable scenario is that the same causative factors for AF
may also impair erythropoiesis, and thereby the observation of an increased RDW
value may only be a coincident epiphenomenon in AF[56]. For example, a high RDW
value is commonplace in patients with recent blood transfusions or severe anemia[13],
and both RBC transfusion[57] and anemia[58] are associated with an excess incidence of
AF,  as  consequence  of  onset  of  heart  failure  and  impairment  of  renal  function.
Inflammation  is  probably  the  most  frequent  cause  of  anisocytosis[59],  but  its
contribution to the pathogenesis of AF is now almost unquestionable, since many
inflammatory cytokines are known to impair atrial electrophysiology and structure[60].
Oxidative stress is another important inducer of anisocytosis[61], whilst the oxidation
of myofibrillar protein and cardiomyocyte membrane lipids is also a well-recognized
mechanism leading  to  AF[62].  Finally,  it  is  now clearly  acknowledged that  renal
diseases may generate a kaleidoscope of inflammatory, neurohumoral, metabolic and
hemodynamic stresses to the heart[63], whilst impaired erythropoiesis and anisocytosis
are  also  commonplace  in  patients  with  impaired  renal  function,  mainly  due  to
impaired erythropoietin production[13] (Figure 2).
On the other hand, a support to the thesis that anisocytosis not only may be an
innocent bystander in AF, but may also trigger, or contribute to worsening, AF has
emerged from a discrete number of studies. Hirayama et al showed that the onset of
arrhythmias is strongly associated with reduced erythrocyte deformability[64], which is
a conventional hallmark of anisocytic erythrocytes[65]. A large variation of erythrocytes
volume is also associated with a greater cholesterol content in the RBC membrane,
which  can  then  be  directly  transferred  to  atherosclerotic  plaques  enriched  in
erythrocytes[66,67], thus finally promoting atherogenesis and ultimately predisposing to
cardiac arrhythmias, since AF atherosclerosis and AF are now considered two strictly
intertwined disorders[68]. Finally, the presence of anisocytic erythrocytes has also been
involved in the mechanisms underlying adverse cardiac remodeling[69], thus leading to
atrial fibrosis and predisposing the patients to a higher risk of developing AF[70].
CONCLUSION
The  value  of  the  RDW  can  be  automatically  generated,  along  with  the  other
parameters of the complete blood cell count, by the majority of modern hematological
analyzers.  It  can therefore be considered an easier,  faster and less expensive test
compared to other potentially useful biomarkers in AF[1]. Regardless of the fact that
anisocytosis may be a simple bystander or an active player in the pathogenesis of AF
and  of  its  life-threatening  complications,  the  current  epidemiological  evidence
convincingly suggests  that  routine measurement  of  RDW may provide valuable
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Figure 2
Figure 2  The interplay between atrial fibrillation and anisocytosis.
clinical information for diagnosis and management of AF, alone or combined with
traditional risk scores such as CHADS2 and CHA2DS2-VASc[71].  In particular, the
strong and often independent association observed between high RDW values and
unfavorable outcomes (e.g., recurrence of AF, heart failure, bleeding, thromboembolic
events and death) (Table 1), would lead us to conclude that AF patients with RDW
values exceeding the local reference range may be more aggressively investigated and
managed, in order to identify and reduce the impact of possible underlying disorders
causing both anisocytosis and AF (Figure 2), and also for preventing the possible risk
of adverse events potentially attributable to anisocytosis. Additional studies are then
advised to define whether the inclusion of RDW within conventional risks scores may
be effective in providing more accurate risk stratification in AF.
REFERENCES
1 O'Neal WT, Venkatesh S, Broughton ST, Griffin WF, Soliman EZ. Biomarkers and the prediction of
atrial fibrillation: state of the art. Vasc Health Risk Manag 2016; 12: 297-303 [PMID: 27486329 DOI:
10.2147/VHRM.S75537]
2 January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz
MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; American
College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014
AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American
College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart
Rhythm Society. J Am Coll Cardiol 2014; 64: e1-76 [PMID: 24685669 DOI: 10.1016/j.jacc.2014.03.022]
3 Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the
CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With
Heart Failure With and Without Atrial Fibrillation. JAMA 2015; 314: 1030-1038 [PMID: 26318604 DOI:
10.1001/jama.2015.10725]
4 Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB,
Anderson JL, Mallender C, Bunch TJ. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on
long-term outcomes after atrial fibrillation ablation. Heart Rhythm 2015; 12: 681-686 [PMID: 25546809
DOI: 10.1016/j.hrthm.2014.12.034]
5 Ruff CT, Giugliano RP, Braunwald E, Murphy SA, Brown K, Jarolim P, Mercuri M, Antman EM,
Morrow DA. Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation:
A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. JAMA Cardiol 2016; 1: 999-1006
[PMID: 27706467 DOI: 10.1001/jamacardio.2016.3311]
6 Fernández-Ruiz I. Atrial fibrillation: New score for stroke risk. Nat Rev Cardiol 2016; 13: 634-635
[PMID: 27629514 DOI: 10.1038/nrcardio.2016.156]
7 Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C,
Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L; ARISTOTLE and RE-LY
Investigators. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC
(age, biomarkers, clinical history) death risk score. Eur Heart J 2018; 39: 477-485 [PMID: 29069359 DOI:
10.1093/eurheartj/ehx584]
8 Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna
WJC https://www.wjgnet.com December 26, 2019 Volume 11 Issue 12
Lippi G et al. Red blood cell distribution in atrial fibrillation
301
M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Repeated Measurements of Cardiac
Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. J Am Heart Assoc
2017; 6 [PMID: 28645934 DOI: 10.1161/JAHA.116.004851]
9 Imataka K, Nakaoka H, Kitahara Y, Fujii J, Ishibashi M, Yamaji T. Blood hematocrit changes during
paroxysmal atrial fibrillation. Am J Cardiol 1987; 59: 172-173 [PMID: 3812234 DOI:
10.1016/s0002-9149(87)80099-1]
10 Takahashi N, Ashida T, Kiraku J, Fujii J. Increase in erythrocyte volume in patients with chronic atrial
fibrillation. Jpn Heart J 1997; 38: 387-391 [PMID: 9290573 DOI: 10.1536/ihj.38.387]
11 Lippi G, Pavesi F, Bardi M, Pipitone S. Lack of harmonization of red blood cell distribution width
(RDW). Evaluation of four hematological analyzers. Clin Biochem 2014; 47: 1100-1103 [PMID:
24925288 DOI: 10.1016/j.clinbiochem.2014.06.003]
12 Fischbach FT, Dunning MB. A manual of laboratory and diagnostic tests. 9th ed. Philadelphia: Wolters
Kluwer Health; 2015;
13 Sarma PR. Red Cell Indices. Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History,
Physical, and Laboratory Examinations. Boston; 1990; 720-723
14 Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: A simple
parameter with multiple clinical applications. Crit Rev Clin Lab Sci 2015; 52: 86-105 [PMID: 25535770
DOI: 10.3109/10408363.2014.992064]
15 Lippi G, Cervellin G, Sanchis-Gomar F. Red blood cell distribution width and cardiovascular disorders.
Does it really matter which comes first, the chicken or the egg? Int J Cardiol 2016; 206: 129-130 [PMID:
26788688 DOI: 10.1016/j.ijcard.2016.01.122]
16 Lippi G, Cervellin G. Risk assessment of post-infarction heart failure. Systematic review on the role of
emerging biomarkers. Crit Rev Clin Lab Sci 2014; 51: 13-29 [PMID: 24410541 DOI:
10.3109/10408363.2013.863267]
17 Lippi G, Buonocore R, Cervellin G. Value of Red Blood Cell Distribution Width on Emergency
Department Admission in Patients With Venous Thrombosis. Am J Cardiol 2016; 117: 670-675 [PMID:
26718227 DOI: 10.1016/j.amjcard.2015.11.024]
18 Lippi G, Favalor EJ, Simundic AM. Biomedical research platforms and their influence on article
submissions and journal rankings: an update. Biochem Med (Zagreb) 2012; 22: 7-14 [PMID: 22384515]
19 Horne BD, May HT, Kfoury AG, Renlund DG, Muhlestein JB, Lappé DL, Rasmusson KD, Bunch TJ,
Carlquist JF, Bair TL, Jensen KR, Ronnow BS, Anderson JL. The Intermountain Risk Score (including the
red cell distribution width) predicts heart failure and other morbidity endpoints. Eur J Heart Fail 2010; 12:
1203-1213 [PMID: 20705688 DOI: 10.1093/eurjhf/hfq115]
20 Providência R, Ferreira MJ, Gonçalves L, Faustino A, Paiva L, Fernandes A, Barra S, Pimenta J, Leitão-
Marques AM. Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in
patients with non-valvular atrial fibrillation. Am J Cardiovasc Dis 2013; 3: 91-102 [PMID: 23785587]
21 Liu T, Shao Q, Miao S, Liu E, Xu G, Yuan R, Li G. Red cell distribution width as a novel, inexpensive
marker for paroxysmal atrial fibrillation. Int J Cardiol 2014; 171: e52-e53 [PMID: 24360079 DOI:
10.1016/j.ijcard.2013.11.112]
22 Ertaş G, Aydin C, Sönmez O, Erdoğan E, Turfan M, Tasal A, Bacaksiz A, Vatankulu MA, Uyarel H,
Ergelen M, Zeybek R, Göktekin Ö. Red cell distribution width predicts new-onset atrial fibrillation after
coronary artery bypass grafting. Scand Cardiovasc J 2013; 47: 132-135 [PMID: 23035619 DOI:
10.3109/14017431.2012.736636]
23 Ertaş G, Sönmez O, Turfan M, Kul S, Erdoğan E, Tasal A, Bacaksiz A, Vatankulu MA, Altıntaş O,
Uyarel H, Göktekin O. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients
with non-valvular atrial fibrillation. J Neurol Sci 2013; 324: 49-52 [PMID: 23084070 DOI:
10.1016/j.jns.2012.09.032]
24 Kurt M, Tanboga IH, Buyukkaya E, Karakas MF, Akçay AB, Sen N. Relation of red cell distribution
width with CHA2DS2-VASc score in patients with nonvalvular atrial fibrillation. Clin Appl Thromb
Hemost 2014; 20: 687-692 [PMID: 23430929 DOI: 10.1177/1076029613478157]
25 Güngör B, Özcan KS, Erdinler İ, Ekmekçi A, Alper AT, Osmonov D, Çalık N, Akyuz S, Toprak E,
Yılmaz H, Yıldırım A, Bolca O. Elevated levels of RDW is associated with non-valvular atrial fibrillation.
J Thromb Thrombolysis 2014; 37: 404-410 [PMID: 23821044 DOI: 10.1007/s11239-013-0957-1]
26 Adamsson Eryd S, Borné Y, Melander O, Persson M, Smith JG, Hedblad B, Engström G. Red blood cell
distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014; 275: 84-92 [PMID:
24112470 DOI: 10.1111/joim.12143]
27 Sarikaya S, Şahin Ş, Akyol L, Börekçi E, Yilmaz YK, Altunkaş F, Karaman K. Is there any relationship
between RDW levels and atrial fibrillation in hypertensive patient? Afr Health Sci 2014; 14: 267-272
[PMID: 26060490 DOI: 10.4314/ahs.v14i1.41]
28 Gurses KM, Yalcin MU, Kocyigit D, Evranos B, Ates AH, Yorgun H, Sahiner ML, Kaya EB, Ozer N,
Oto MA, Aytemir K. Red blood cell distribution width predicts outcome of cryoballoon-based atrial
fibrillation ablation. J Interv Card Electrophysiol 2015; 42: 51-58 [PMID: 25510648 DOI:
10.1007/s10840-014-9959-y]
29 Korantzopoulos P, Sontis N, Liu T, Chlapoutakis S, Sismanidis S, Siminelakis S, Apostolakis E.
Association between red blood cell distribution width and postoperative atrial fibrillation after cardiac
surgery: A pilot observational study. Int J Cardiol 2015; 185: 19-21 [PMID: 25777283 DOI:
10.1016/j.ijcard.2015.03.080]
30 Wan H, Yang Y, Zhu J, Huang B, Wang J, Wu S, Shao X, Zhang H. The relationship between elevated
red cell distribution width and long-term outcomes among patients with atrial fibrillation. Clin Biochem
2015; 48: 762-767 [PMID: 26054582 DOI: 10.1016/j.clinbiochem.2015.06.001]
31 Lee KH, Park HW, Cho JG, Yoon NS, Kim SS, Kim MR, Kim MC, Cho KH, Kim HK, Kim CH, Kim
KH, Jun SJ, Kim WJ, Lee KJ, Jeong HC, Cho JY, Park KH, Sim Ds, Yoon HJ, Kim KH, Hong YJ, Kim
JH, Ahn Y, Jeong MH, Park JC. Red cell distribution width as a novel predictor for clinical outcomes in
patients with paroxysmal atrial fibrillation. Europace 2015; 17 Suppl 2: ii83-ii88 [PMID: 26842121 DOI:
10.1093/europace/euv210]
32 Zhao J, Liu T, Korantzopoulos P, Fu H, Shao Q, Suo Y, Zheng C, Xu G, Liu E, Xu Y, Zhou C, Li G. Red
blood cell distribution width and left atrial thrombus or spontaneous echo contrast in patients with non-
valvular atrial fibrillation. Int J Cardiol 2015; 180: 63-65 [PMID: 25438214 DOI:
10.1016/j.ijcard.2014.11.145]
33 Aksu T, Baysal E, Guler TE, Golcuk SE, Erden İ, Ozcan KS. Predictors of atrial fibrillation recurrence
after cryoballoon ablation. J Blood Med 2015; 6: 211-217 [PMID: 26170730 DOI: 10.2147/JBM.S81551]
WJC https://www.wjgnet.com December 26, 2019 Volume 11 Issue 12
Lippi G et al. Red blood cell distribution in atrial fibrillation
302
34 Korantzopoulos P, Kyrlas K, Liu T, Li G, Goudevenos JA. Red blood cell distribution width and atrial
fibrillation in patients with sick sinus syndrome. J Cardiol 2016; 67: 551-554 [PMID: 26321105 DOI:
10.1016/j.jjcc.2015.07.013]
35 Karataş MB, Çanga Y, İpek G, Özcan KS, Güngör B, Durmuş G, Onuk T, Öz A, Şimşek B, Bolca O.
Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary
percutaneous coronary intervention. Coron Artery Dis 2016; 27: 128-134 [PMID: 26693808 DOI:
10.1097/MCA.0000000000000333]
36 Yanagisawa S, Inden Y, Kato H, Miyoshi A, Mizutani Y, Ito T, Kamikubo Y, Kanzaki Y, Hirai M,
Murohara T. Elevated Red Blood Cell Distribution Width Predicts Recurrence After Catheter Ablation for
Atrial Fibrillation in Patients With Heart Failure - Comparison With Non-Heart Failure Patients. Circ J
2016; 80: 627-638 [PMID: 26823143 DOI: 10.1253/circj.CJ-15-1152]
37 Vizzardi E, Sciatti E, Bonadei I, Pezzali NL, Lombardi CM, Metra M. Red cell distribution width and
chronic heart failure: prognostic role beyond echocardiographic parameters. Monaldi Arch Chest Dis 2016;
84: 59 [PMID: 27374035 DOI: 10.4081/monaldi.2015.59]
38 Geçmen Ç, Babür Güler G, Erdoğan E, Hatipoğlu S, Güler E, Yılmaz F, Unkun T, Cap M, Bengi Bakal R,
Bayram T, Deniz Acar R, Candan Ö, Özdemir N. SYNTAX score predicts postoperative atrial fibrillation
in patients undergoing on-pump isolated coronary artery bypass grafting surgery. Anatol J Cardiol 2016;
16: 655-661 [PMID: 27488747 DOI: 10.5152/AnatolJCardiol.2015.6483]
39 Zhang Q, Qin Y, Zhao DS, Zhao HP, Zhou L. Prognostic Value of Red Blood Cell Distribution Width on
Bleeding Events in Nonvalvular Atrial Fibrillation Patients Taking Dabigatran (110 mg b.i.d.) after
Catheter Ablation. Cardiology 2017; 136: 215-221 [PMID: 27802430 DOI: 10.1159/000449461]
40 Al-Kindi SG, Kim CH, Morris SR, Freeman ML, Funderburg NT, Rodriguez B, McComsey GA, Dalton
JE, Simon DI, Lederman MM, Longenecker CT, Zidar DA. Brief Report: Elevated Red Cell Distribution
Width Identifies Elevated Cardiovascular Disease Risk in Patients With HIV Infection. J Acquir Immune
Defic Syndr 2017; 74: 298-302 [PMID: 27828877 DOI: 10.1097/QAI.0000000000001231]
41 Liu T, Shao Q, Korantzopoulos P, Miao S, Zhang Z, Xu G, Yuan R, Li G. Relation of red blood cell
distribution width with CHADS2 and CHA2DS2-VASc score in Chinese patients with non-valvular atrial
fibrillation. Int J Cardiol 2017; 228: 861-864 [PMID: 27889552 DOI: 10.1016/j.ijcard.2016.11.255]
42 Saliba W, Barnett-Griness O, Rennert G. Red cell distribution width and all-cause mortality in patients
with atrial fibrillation: A cohort study. J Arrhythm 2017; 33: 56-62 [PMID: 28217230 DOI:
10.1016/j.joa.2016.06.001]
43 Kaya A, Tukkan C, Alper AT, Gungor B, Ozcan KS, Tatlisu MA, Tekkesin AI, Karadeniz FO, Gok G,
Kayapinar O. Increased levels of red cell distribution width is correlated with presence of left atrial stasis
in patients with non-valvular atrial fibrillation. North Clin Istanb 2017; 4: 66-72 [PMID: 28752145 DOI:
10.14744/nci.2017.72324]
44 Cha MJ, Lee HS, Kim HM, Jung JH, Choi EK, Oh S. Association between red cell distribution width and
thromboembolic events in patients with atrial fibrillation. Eur J Intern Med 2017; 46: 41-46 [PMID:
28781193 DOI: 10.1016/j.ejim.2017.07.028]
45 Nam JH, Park KH, Lee JH, Lee CH, Son JW, Kim U, Park JS, Shin DG. Discordant Relationships
between Systemic Inflammatory Markers and Burden of Oxidative Stress in Patients with Atrial
Fibrillation. Korean Circ J 2017; 47: 752-761 [PMID: 28955393 DOI: 10.4070/kcj.2017.0024]
46 Wasilewski J, Pyka Ł, Hawranek M, Tajstra M, Skrzypek M, Wasiak M, Suliga K, Bujak K, Gąsior M.
Prognostic value of red blood cell distribution width in patients with left ventricular systolic dysfunction:
Insights from the COMMIT-HF registry. Cardiol J 2018; 25: 377-385 [PMID: 28353308 DOI:
10.5603/CJ.a2017.0037]
47 Cerşit S, Kalçik M, Öcal L, Bayam E. Association between atrial fibrillation and red cell distribution
width in patients with acute coronary syndrome. Medeniyet Medical Journal 2018; 33: 89-93 [DOI:
10.5222/MMJ.2018.58234]
48 Kılıcgedik A, Naser A, Gurbuz AS, Kulahcioglu S, Bakal RB, Unkun T, Yilmaz F, Kahveci G, Kirma C.
Red Cell Distribution Width with CHADS2 and CHA2DS2-VASc score is associated with Post-operative
Atrial Fibrillation after Coronary Artery Bypass Grafting. Heart Surg Forum 2018; 21: E170-E174
[PMID: 29893674 DOI: 10.1532/hsf.1886]
49 Ozsin KK, Sanri US, Toktas F, Yavuz S. Relationship between red cell distribution width and mean
platelet volume with new onset atrial fibrillation afteroff-pump coronary artery bypass grafting. Bratisl Lek
Listy 2018; 119: 335-340 [PMID: 29947232 DOI: 10.4149/BLL_2018_063]
50 Pilling LC, Atkins JL, Kuchel GA, Ferrucci L, Melzer D. Red cell distribution width and common disease
onsets in 240,477 healthy volunteers followed for up to 9 years. PLoS One 2018; 13: e0203504 [PMID:
30212481 DOI: 10.1371/journal.pone.0203504]
51 Han K, Su X, Liu J, Yao F, Lu F. Red Cell Distribution Width as a Novel Marker for Different Types of
Atrial Fibrillation in Low and High Altitude. Cardiol Res Pract 2019; 2019: 6291964 [PMID: 30984423
DOI: 10.1155/2019/6291964]
52 Jurin I, Hadžibegović I, Durlen I, Jakšić Jurinjak S, Mišković D, Ajduk M, Jerkić H, Letilović T. Left
atrium size and red cell distribution width predict atrial fibrillation progression from paroxysmal or
persistent to permanent. Acta Clin Belg 2019; 1-7 [PMID: 30950766 DOI:
10.1080/17843286.2019.1599173]
53 Li H, Gu Y, Liu M, Wang X, Chi VTQ, Zhang Q, Liu L, Meng G, Yao Z, Wu H, Bao X, Zhang S, Kumari
S, Sun S, Zhou M, Jia Q, Song K, Wu Y, Liu T, Niu K. The relationship between red blood cell
distribution width and atrial fibrillation in Asian population: A cross-sectional study. Pacing Clin
Electrophysiol 2019; 42: 1197-1203 [PMID: 31397913 DOI: 10.1111/pace.13776]
54 Shao Q, Korantzopoulos P, Letsas KP, Tse G, Hong J, Li G, Liu T. Red blood cell distribution width as a
predictor of atrial fibrillation. J Clin Lab Anal 2018; 32: e22378 [PMID: 29315856 DOI:
10.1002/jcla.22378]
55 Weymann A, Ali-Hasan-Al-Saegh S, Popov AF, Sabashnikov A, Mirhosseini SJ, Liu T, Tse G, Lotfaliani
M, Ghanei A, Testa L, D'Ascenzo F, Benedetto U, Dehghan H, Roever L, Sá MPBO, Baker WL, Yavuz S,
Zeriouh M, Mashhour A, Nombela-Franco L, Jang JS, Meng L, Gong M, Deshmukh AJ, Palmerini T,
Linde C, Filipiak KJ, Biondi-Zoccai G, Calkins H, Stone GW. Haematological indices as predictors of
atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery, or combined
procedures: a systematic review with meta-analysis. Kardiol Pol 2018; 76: 107-118 [PMID: 28980298
DOI: 10.5603/KP.a2017.0179]
56 Jagannathan-Bogdan M, Zon LI. Hematopoiesis. Development 2013; 140: 2463-2467 [PMID: 23715539
DOI: 10.1242/dev.083147]
WJC https://www.wjgnet.com December 26, 2019 Volume 11 Issue 12
Lippi G et al. Red blood cell distribution in atrial fibrillation
303
57 Alameddine AK, Visintainer P, Alimov VK, Rousou JA. Blood transfusion and the risk of atrial
fibrillation after cardiac surgery. J Card Surg 2014; 29: 593-599 [PMID: 24965706 DOI:
10.1111/jocs.12383]
58 Ali AN, Athavale NV, Abdelhafiz AH. Anemia: An Independent Predictor Of Adverse Outcomes In Older
Patients With Atrial Fibrillation. J Atr Fibrillation 2016; 8: 1366 [PMID: 27909494 DOI:
10.4022/jafib.1366]
59 Lippi G, Targher G, Montagnana M, Salvagno GL, Zoppini G, Guidi GC. Relation between red blood cell
distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol
Lab Med 2009; 133: 628-632 [PMID: 19391664 DOI: 10.1043/1543-2165-133.4.628]
60 Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev
Cardiol 2015; 12: 230-243 [PMID: 25622848 DOI: 10.1038/nrcardio.2015.2]
61 Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox
Signal 2008; 10: 1923-1940 [PMID: 18707226 DOI: 10.1089/ars.2008.2142]
62 Yang KC, Dudley SC. Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle.
Circulation 2013; 128: 1724-1726 [PMID: 24030497 DOI: 10.1161/CIRCULATIONAHA.113.005837]
63 McManus DD, Saczynski JS, Ward JA, Jaggi K, Bourrell P, Darling C, Goldberg RJ. The Relationship
Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic
Considerations for a Dual Epidemic. J Atr Fibrillation 2012; 5: 442 [PMID: 28496745 DOI:
10.4022/jafib.442]
64 Hirayama T, Roberts D, Allers M, Belboul A, al-Khaja N, William-Olsson G. Association between
arrhythmias and reduced red cell deformability following cardiopulmonary bypass. Scand J Thorac
Cardiovasc Surg 1988; 22: 179-180 [PMID: 3406694 DOI: 10.3109/14017438809105954]
65 Patel KV, Mohanty JG, Kanapuru B, Hesdorffer C, Ershler WB, Rifkind JM. Association of the red cell
distribution width with red blood cell deformability. Adv Exp Med Biol 2013; 765: 211-216 [PMID:
22879035 DOI: 10.1007/978-1-4614-4989-8_29]
66 Tziakas D, Chalikias G, Grapsa A, Gioka T, Tentes I, Konstantinides S. Red blood cell distribution width:
a strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte
membrane. Clin Hemorheol Microcirc 2012; 51: 243-254 [PMID: 22277951 DOI:
10.3233/CH-2012-1530]
67 Tziakas DN, Chalikias GK, Stakos D, Tentes IK, Papazoglou D, Thomaidi A, Grapsa A, Gioka G, Kaski
JC, Boudoulas H. Independent and additive predictive value of total cholesterol content of erythrocyte
membranes with regard to coronary artery disease clinical presentation. Int J Cardiol 2011; 150: 22-27
[PMID: 20223535 DOI: 10.1016/j.ijcard.2010.02.022]
68 Willeit K, Kiechl S. Atherosclerosis and atrial fibrillation--two closely intertwined diseases.
Atherosclerosis 2014; 233: 679-681 [PMID: 24569021 DOI: 10.1016/j.atherosclerosis.2013.11.082]
69 Fujii T, Nishigaki R, Kawahara K, Yamada N, Onda M, Yokoyama M, Naito Z, Asano G, Shimizu-
Suganuma M, Shichinohe K. Ultrastructural changes and immunohistochemical localization of advanced
glycation end products in the heart of streptozotocin-treated Mongolian gerbils. Med Electron Microsc
1999; 32: 43-49 [PMID: 11810424 DOI: 10.1007/s007959900021]
70 Shimano M, Tsuji Y, Inden Y, Kitamura K, Uchikawa T, Harata S, Nattel S, Murohara T. Pioglitazone, a
peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation
promotion in rabbits with congestive heart failure. Heart Rhythm 2008; 5: 451-459 [PMID: 18313605
DOI: 10.1016/j.hrthm.2007.12.010]
71 Chen JY, Zhang AD, Lu HY, Guo J, Wang FF, Li ZC. CHADS2 versus CHA2DS2-VASc score in
assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic
review and meta-analysis. J Geriatr Cardiol 2013; 10: 258-266 [PMID: 24133514 DOI:
10.3969/j.issn.1671-5411.2013.03.004]
WJC https://www.wjgnet.com December 26, 2019 Volume 11 Issue 12
Lippi G et al. Red blood cell distribution in atrial fibrillation
304
